Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04704609 · ClinicalTrials.gov registry record
Imaging Quantification of Inflammation (IQI)
A clinical trial of Uveitis, sponsored by The Cleveland Clinic.
- Active
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT04704609 is a study of Uveitis that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 50 participants, below the 615-participant average among 19 other Uveitis trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04704609, a study of Uveitis, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
1\. Perform observational study utilizing real-time quantification of ocular inflammation to determine minimal important change. Prospective use of changes in imaging quantification of inflammation (IQI) scores in determining treatment decisions both utilizing novel FA viewer software.
Conditions Studied
Interventions
- OTHER Standard of Care Imaging
Study Locations (1)
Ohio
- Cleveland Clinic Foundation Cole Eye Institute - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-09-22 |
| Est. Completion | 2027-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04704609
The ClinicalTrials.gov registry entry for NCT04704609 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 615-participant average among 19 other Uveitis trials with a reported enrollment target (92% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uveitis appearing as the primary indexed condition, and to 1 intervention - of which Standard of Care Imaging is the first listed.
NCT04704609 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04704609 about?
NCT04704609 is a clinical study titled "Imaging Quantification of Inflammation (IQI)". 1\. Perform observational study utilizing real-time quantification of ocular inflammation to determine minimal important change. Prospective use of changes in imaging quantification of inflammation (IQI) scores in determining treatment decisions both utilizing novel FA viewer software.
What is the current status of trial NCT04704609?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2019-09-22. Estimated completion is 2027-09-30.
What conditions does trial NCT04704609 study?
This clinical trial studies the following conditions: Uveitis.
What interventions are being tested in trial NCT04704609?
The interventions under investigation include: Standard of Care Imaging (OTHER).
Who is sponsoring clinical trial NCT04704609?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04704609 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uveitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
RECRUITING
-
Genetics of Uveitis
RECRUITING
-
Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography
RECRUITING
-
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
RECRUITING · NA
-
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
RECRUITING · Phase 3
-
Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.